Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Carl Borrebaeck blir vicerektor i Lund

Universitetsledningen i Lund förstärks med tre nya vicerektorer. Dessutom blir det en extra satsning på ledarskap, lärarskap och innovationer.

Sophion etablerar sig i Japan

Öppnar nytt sälj och supportkontor som ska ledas av en ledande japansk elektrofysiolog.

Chr. Hansen köper underlivshälsa

Nio studer har bevisat att Urex kan minska risken för underlivsinfektioner hos kvinnor. Nu flyttas det kanadensiska bolagets verksamhet till Köpenhamn.

Danska elitforskare belönas

Totalt 45 forskare får dela på 12 miljoner vid årets utdelning av det danska Eliteforskpriset. Ett av årets stora EliteForskpris går till en ung hjärnforskare som forskar kring Alzheimers sjukdom och hjärnskador.

Hårt tryck på Läkemedelsverket

Alltför många vill ansöka om Sverige som referensland i den decentraliserade processen för att godkänna läkemedel. Idag införs nya rutiner för att hantera situationen.

Han blir Alphahelix nya VD

Bolagets tidigare teknikchef tar ett steg upp.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Swedish Medtech söker ekonom/jurist

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a small illuminating lens.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.